Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 159 | 51 | 106 |
| Samples | 157 | 50 | 105 |
| Peptides | 115 | 38 | 80 |
Function
TLNRD1 · Talin rod domain containing 1
This gene encodes a protein that is regulated by micro RNA MiR-574-3, and is thought to have an oncogenic function in human bladder cancer. A similar gene in mouse is located in a chromosomal region critical for differentiation of mesoderm, which affects embryo patterning and the formation of heart, muscle, blood, skeleton and the urogenital system. The mouse gene is expressed in early development, and in the adult. [provided by RefSeq, Nov 2016].
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000267984 | Q9H1K6 | 159 | 115 |
Gene Properties
Recurrent Mutations
All 115 amino-acid changes on canonical ENST00000267984 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in TLNRD1 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in TLNRD1 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Chronic Myelogenous Leukemia | 2/25 8% | 0/0 0% |
| T-Lymphoblastic Leukemia | 2/40 5% | 0/0 0% |
| Hodgkins Lymphoma | 2/16 12% | 1/122 1% |
| Glioblastoma | 2/98 2% | 0/0 0% |
| Burkitts Lymphoma | 2/32 6% | 1/196 1% |
| Acute Myeloid Leukemia | 1/90 1% | 0/0 0% |
| Gastric Carcinoma | 1/74 1% | 16/1809 1% |
| Melanoma | 7/210 3% | 11/1899 1% |
| Non-Small Cell Lung Carcinoma | 5/304 2% | 7/1390 0% |
| Small Cell Lung Carcinoma | 2/9 22% | 3/752 0% |
| Colorectal Carcinoma | 10/143 7% | 11/3239 0% |
| Other Solid Cancers | 3/94 3% | 5/1515 0% |
| Bladder Carcinoma | 1/58 2% | 4/956 0% |
| Endometrial Carcinoma | 0/42 0% | 3/612 0% |
| Esophageal Squamous Cell Carcinoma | 0/51 0% | 11/2550 0% |
| Meningioma | 0/3 0% | 1/252 0% |
| Other Sarcomas | 0/69 0% | 3/699 0% |
| Pancreatic Carcinoma | 1/89 1% | 5/1611 0% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 3/810 0% |
| Biliary Tract Carcinoma | 1/54 2% | 2/950 0% |
| Head and Neck Carcinoma | 0/85 0% | 4/1574 0% |
| Thyroid Gland Carcinoma | 0/45 0% | 4/1592 0% |
| Glioma | 0/52 0% | 3/2127 0% |
| Esophageal Carcinoma | 0/23 0% | 1/769 0% |
| B-Cell Non-Hodgkins Lymphoma | 1/88 1% | 2/2534 0% |
| B-Lymphoblastic Leukemia | 3/55 5% | 0/2640 0% |
| Hepatocellular Carcinoma | 1/46 2% | 1/2210 0% |
| Ovarian Carcinoma | 0/109 0% | 1/998 0% |
| Breast Carcinoma | 1/144 1% | 2/3264 0% |
| Other Blood Cancers | 2/61 3% | 0/2725 0% |
Mutation Distribution
Where TLNRD1 is mutated · all tissues, split by cell line vs tissue
How many mutations in TLNRD1 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
Mutations
All 159 mutations in TLNRD1
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|